Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 460941

Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia


Rojnić Kuzman, Martina; Medved, Vesna; Božina, Nada; Grubišin, Jasmina; Jovanović, Nikolina; Sertić, Jadranka
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia // Pharmacogenomics journal, 11 (2011), 1; 35-44 doi:10.1038/tpj.2010.7 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 460941 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia

Autori
Rojnić Kuzman, Martina ; Medved, Vesna ; Božina, Nada ; Grubišin, Jasmina ; Jovanović, Nikolina ; Sertić, Jadranka

Izvornik
Pharmacogenomics journal (1470-269X) 11 (2011), 1; 35-44

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
5-HT2C; MDR1; genetic polymorphism; metabolic abnormalities;
(5-HT2C; MDR1; genetic polymorphism; metabolic abnormalities)

Sažetak
The objective of this study was to determine the association of 5-HT2C (serotonin 2C receptor) and MDR1 (multidrug resistant protein) genetic polymorphisms and antipsychotic-induced metabolic abnormalities among female patients with DSM IV schizophrenia spectrum disorders. We have previously reported the associations of -759CT 5- HT2C and G2677T and C3435T MDR1 genetic polymorphisms and olanzapine/risperidone-induced weight gain in a similar sample of patients. Here, we included a total of 101 previously non- medicated female patients treated with olanzapine/risperidone over a 3-month period. The variables analyzed included fasting glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein and triglyceride levels in blood, blood pressure and waist circumferences. We observed significant association of -759T 5-HT2C genetic variant and greater increase in waist circumference (P=0.03), fasting glucose level (P=0.046) and triglyceride level (P=0.045) in blood after a 3-month period. The 2677T and 3435T MDR1 genetic variants were significantly associated with the greater increase in fasting glucose level in blood when patients were using olanzapine (P<0.001 and P=0.028, respectively). Our data indicate a possible influence of -759CT 5-HT2C and MDR1 G2677T and C3435T MDR1 genetic polymorphisms on the development of metabolic abnormalities among female patients treated with olanzapine/risperidone.The Pharmacogenomics Journal advance online publication, 2 March 2010 ; doi:10.1038/tpj.2010.7.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1080134-0136 - Funkcijska genomika i proteomika rizičnih čimbenika ateroskleroze (Sertić, Jadranka, MZOS ) ( CroRIS)
108-1083509-3513 - Farmakogenetska varijabilnost u psihijatrijskih bolesnika (Mihaljević-Peleš, Alma, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi www.nature.com

Citiraj ovu publikaciju:

Rojnić Kuzman, Martina; Medved, Vesna; Božina, Nada; Grubišin, Jasmina; Jovanović, Nikolina; Sertić, Jadranka
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia // Pharmacogenomics journal, 11 (2011), 1; 35-44 doi:10.1038/tpj.2010.7 (međunarodna recenzija, članak, znanstveni)
Rojnić Kuzman, M., Medved, V., Božina, N., Grubišin, J., Jovanović, N. & Sertić, J. (2011) Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. Pharmacogenomics journal, 11 (1), 35-44 doi:10.1038/tpj.2010.7.
@article{article, author = {Rojni\'{c} Kuzman, Martina and Medved, Vesna and Bo\v{z}ina, Nada and Grubi\v{s}in, Jasmina and Jovanovi\'{c}, Nikolina and Serti\'{c}, Jadranka}, year = {2011}, pages = {35-44}, DOI = {10.1038/tpj.2010.7}, keywords = {5-HT2C, MDR1, genetic polymorphism, metabolic abnormalities, }, journal = {Pharmacogenomics journal}, doi = {10.1038/tpj.2010.7}, volume = {11}, number = {1}, issn = {1470-269X}, title = {Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia}, keyword = {5-HT2C, MDR1, genetic polymorphism, metabolic abnormalities, } }
@article{article, author = {Rojni\'{c} Kuzman, Martina and Medved, Vesna and Bo\v{z}ina, Nada and Grubi\v{s}in, Jasmina and Jovanovi\'{c}, Nikolina and Serti\'{c}, Jadranka}, year = {2011}, pages = {35-44}, DOI = {10.1038/tpj.2010.7}, keywords = {5-HT2C, MDR1, genetic polymorphism, metabolic abnormalities}, journal = {Pharmacogenomics journal}, doi = {10.1038/tpj.2010.7}, volume = {11}, number = {1}, issn = {1470-269X}, title = {Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia}, keyword = {5-HT2C, MDR1, genetic polymorphism, metabolic abnormalities} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font